Day: 30 June 2020

Greater London

Freeline secures £96 million Series C investment led by Novo

Freeline Closes $120 Million Series C Financing Round Supported by leading international investors led by Novo Holdings A/S, Eventide Asset Management and Wellington Management Company – London, 30 June, 2020 – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline […]Read More


PharmEnable secures £1.8 million Seed investment led by Cambridge Enterprise

Cambridge Spin-out PharmEnable Raises £1.8 million for Drug Discovery Expansion £1.8m seed financing led by Cambridge Enterprise alongside angel investors and life science investment funds Using advanced medicinal chemistry and AI approaches to develop highly complex and specific drug candidate molecules Will enable in-house drug discovery across a number of therapeutic areas including cancer and […]Read More

Greater London secures £5.17 million Seed funding led by Global Founders

June 30th, 2020 closes €5.6M ($6.3M) Seed funding to bring ethical finance to employees in Europe Financial well being represents one of the most challenging problems facing society today. is addressing this problem at its core, providing ethical financial products in partnership with employers to enable employees to better manage their financial and […]Read More